- Home
- MTSI vs ASND Comparison
MTSI vs ASND Comparison
Compare MTSI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | ASND |
|---|---|---|
| Founded | 1950 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1B | 17.7B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MTSI | ASND |
|---|---|---|
| Price | $278.26 | $230.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $257.60 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 1.2M | 777.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.52 | N/A |
| Revenue | ★ $967,258,000.00 | N/A |
| Revenue This Year | $23.55 | $96.35 |
| Revenue Next Year | $17.74 | $44.91 |
| P/E Ratio | $113.41 | ★ N/A |
| Revenue Growth | ★ 32.58 | N/A |
| 52 Week Low | $122.30 | $186.05 |
| 52 Week High | $418.90 | $282.15 |
Technical Indicators
Market Signals| Indicator | MTSI | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 38.70 |
| Support Level | $256.10 | $213.28 |
| Resistance Level | $289.34 | $246.56 |
| Average True Range (ATR) | 11.41 | 10.00 |
| MACD | 3.26 | -3.02 |
| Stochastic Oscillator | 81.26 | 18.43 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.